{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ADMA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T17:24:59.245Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3505,"canonical_name":"ADMA BIOLOGICS, INC.","cik":"0001368514","uei":null,"lei":null,"duns":null,"ticker":"ADMA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":13},"count":13,"timeline":[{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — ADMA BIOLOGICS, INC. — 2026-08-07","url_slug":"/sec/cik-0001368514/schedule-13g/0000093751-26-000402","accession_number":"0000093751-26-000402","importance":55},{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ADMA BIOLOGICS, INC. — 2026-08-05","url_slug":"/sec/cik-0001368514/10-q/0001140361-26-031445","accession_number":"0001140361-26-031445","importance":45},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — ADMA BIOLOGICS, INC. — 2026-08-05","url_slug":"/sec/cik-0001368514/8-k/0001140361-26-031423","accession_number":"0001140361-26-031423","importance":35},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4","title":"4 — ADMA BIOLOGICS, INC. — 2026-07-28","url_slug":"/sec/cik-0001368514/4/0001140361-26-029923","accession_number":"0001140361-26-029923","importance":30},{"ts":"2026-07-24","kind":"sec.insider.3177","reporter":"Kestenberg-Messina Kaitlin M.","title":"COO and SVP, Compliance","shares":3177,"price_per_share":8.37,"usd_value":26591,"security_title":"Common Stock","importance":15.02659149},{"ts":"2026-07-24","kind":"sec.insider.f","reporter":"Kestenberg-Messina Kaitlin M.","title":"COO and SVP, Compliance","shares":3177,"price_per_share":8.37,"usd_value":26591,"security_title":"Common Stock","importance":15.02659149},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — ADMA BIOLOGICS, INC. — 2026-07-17","url_slug":"/sec/cik-0001368514/4/0001140361-26-028844","accession_number":"0001140361-26-028844","importance":30},{"ts":"2026-07-16","kind":"sec.insider.a","reporter":"Kohler Terry","title":"CFO and Treasurer","shares":85130,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-02","kind":"sec.filing","form_type":"8-K","title":"8-K — ADMA BIOLOGICS, INC. — 2026-06-02","url_slug":"/sec/cik-0001368514/8-k/0001140361-26-023705","accession_number":"0001140361-26-023705","importance":35},{"ts":"2026-05-14","kind":"sec.filing","form_type":"4","title":"4 — ADMA BIOLOGICS, INC. — 2026-05-14","url_slug":"/sec/cik-0001368514/4/0001140361-26-021150","accession_number":"0001140361-26-021150","importance":30},{"ts":"2026-05-12","kind":"sec.insider.p","reporter":"Grossman Jerrold B","title":null,"shares":12500,"price_per_share":8.01,"usd_value":100125,"security_title":"Common Stock","importance":50.100125},{"ts":"2026-05-12","kind":"sec.filing","form_type":"4","title":"4 — ADMA BIOLOGICS, INC. — 2026-05-12","url_slug":"/sec/cik-0001368514/4/0001140361-26-020855","accession_number":"0001140361-26-020855","importance":30},{"ts":"2026-05-11","kind":"sec.insider.p","reporter":"Grossman Jerrold B","title":null,"shares":12500,"price_per_share":8.01,"usd_value":100125,"security_title":"Common Stock","importance":50.100125}]}